Why is Aspira Pathlab falling/rising?

As of 08-Oct, Aspira Pathlab & Diagnostics Ltd is experiencing a decline in its stock price, currently at Rs 62.14, which represents a decrease of 3.27 or 5.0%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 13.31% during this period. Today, it opened with a loss of 4.94% and reached an intraday low of Rs 62.14. Additionally, the stock's delivery volume has decreased significantly, falling by 31.91% against the five-day average, indicating a drop in investor participation. While the stock's performance year-to-date shows a positive return of 4.44%, it has underperformed the Sensex over the past week and month, with declines of 8.98% and 1.37%, respectively.
In the broader market context, the Sensex has shown a positive return of 0.98% over the past week and 1.22% over the past month, contrasting sharply with Aspira's negative performance. This suggests that the stock's decline is not reflective of the overall market trend, which may indicate company-specific issues rather than broader economic factors. The stock is currently trading above its 100-day moving average but below its shorter-term moving averages, which may signal a bearish trend in the near term. Overall, the combination of falling investor participation and underperformance relative to the benchmark suggests that Aspira Pathlab is facing challenges that are impacting its stock price negatively.